Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: Implications for cerebral amyloid angiopathy

Laboratory Investigation

Volumn 77, Issue 2, 1997, Pages 157-166

  Urmoneit, Britta ^a   Prikulis, Ingrid ^a   Wihl, Günther ^d   D'Urso, Donatella ^a   Frank, Rainer ^c   Heeren, Jörg ^b   Beisiegel, Ulrike ^b   Prior, Reinhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BREFELDIN A; CHLOROQUINE; CYCLOHEXIMIDE; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN BLOOD VESSEL; DEGENERATIVE DISEASE; ENDOCYTOSIS; GENOTYPE; HUMAN; HUMAN CELL; INTERNALIZATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; VASCULAR SMOOTH MUSCLE;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEINS E; BRAIN; CELLS, CULTURED; CEREBRAL AMYLOID ANGIOPATHY; DOGS; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, IMMUNOLOGIC;

EID: 0030833577     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Abrahamson M, Jonsdottir S, Olafsson I, Jensson O, and Grubb A (1992). Hereditary cystatin C amyloid angiopathy: Identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 89:377-380.
2. Ard MD, Cole GM, Wei J, Mehrle AP, and Fratkin JD (1996). Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. Neurosci Res 43:190-202.
3. Arinami T, Takekoshi K, Yanagi H, Hamamoto M, and Hamaguchi H (1996). The 5-repeat allele in the very-low-density lipoprotein receptor gene polymorphism is not increased in sporadic Alzheimer's disease in Japanese. Neurology 47:1349-1350.
4. Beisiegel U, Weber W, Ihrke G, Herz J, and Stanley KK (1989). The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341:162-164.
5. Bickel PE and Freeman MW (1992). Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 90:1450-1457.
6. Burdick D, Kosmoski J, Knauer MF, and Glabe CG (1997). Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ 1-42, in differentiated PC12 cells. Brain Res 746:275-284.
7. Carlsson SR, Roth J, Piller F, and Fukuda M (1988). Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. J Biol Chem 263:18911-18919.
8. Chung H, Roberts CT, Greenberg S, Rebeck GW, Christie R, Wallace R, Jacob HJ, and Hyman BT (1996). Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann Neurol 39:800-803.
9. Coste J, Le-Nguyen D, and Castro B (1990). PyBOP: A new peptide coupling reagent devoid of toxic by-product. Tetrahedron Lett 31:205-208.
10. Cummings BJ, Su JH, Cotman CW, White R, and Russell MJ (1993). Beta-amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease. Neurobiol Aging 14:547-560.
11. Davis Salinas J, Saporito Irwin SM, Cotman CW, and Van Nostrand WE (1995). Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 65:931-934.
12. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, and Heyman A (1996). Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV. Neurology 46:1592-1596.
13. Fagan AM, Bu G, Sun Y, Daughterty A, and Holtzman DM (1996). Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 271:30121-30125.
14. Frackowiak J, Mazur Kolecka B, Wisniewski HM, Potempska A, Carroll RT, Emmerling MR, and Kim KS (1995). Secretion and accumulation of Alzheimer's beta-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res 676:225-230.
15. Frackowiak J, Zoltowska A, and Wisniewski HM (1994). Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 53:637-645.
16. Frank R and Gausepohl H (1988). Continuous flow peptide synthesis. In: Tschesche H, editor. Modern methods in protein chemistry, vol 3. New York: De Gruyter, 42-60.
17. Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR, and Tagliavini F (1996). Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744-748.
18. Ghiso J, Pons Estel B, and Frangione B (1986). Hereditary cerebral amyloid angiopathy: The amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem Biophys Res Commun 136:548-554.
19. Glenner GG and Wong CW (1984). Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
20. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L, Jr., Younkin LH, Suzuki N, and Younkin SG (1995). Amyloid beta protein (A beta) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem 270:7013-7016.
21. Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, Kase CS, and Pessin MS (1996). Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27:1333-1337.
22. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez Isla T, and Hyman BT (1995). Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38:254-259.
23. Guillaume D, Bertrand P, Dea D, Davignon D, and Poirier J (1996). Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: Isoform-specific alterations. J Neurochem 66:2410-2418.
24. Haltia M, Ghiso J, Prelli F, Gallo G, Kiuru S, Somer H, Palo J, and Frangione B (1990). Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 136:1223-1228.
25. Ida N, Masters CL, and Beyreuther K (1996). Rapid cellular uptake of Alzheimer amyloid beta A4 peptide by cultured human neuroblastoma cells. FEBS Lett 394:174-178.
26. Itoh Y, Yamada M, Hayakawa M, Otomo E, and Miyatake T (1993). Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116:135-141.
27. Jarrett JT, Berger EP, and Lansbury PJ (1993). The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
28. Johnstone EM, Chaney MO, Norris FH, Pascual R, and Little SP (1991). Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res 10:299-305.
29. Kametani F, Ikeda S, Yanagisawa N, Ishi T, and Hanyu N (1992). Characterization of a transthyretin-related amyloid fibril protein from cerebral amyloid angiopathy in type I familial amyloid polyneuropathy. J Neurol Sci 108:178-183.
30. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, and Muller-Hill B (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
31. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, and Perry G (1993). Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 623:142-146.
32. Knauer MF, Soreghan B, Burdick D, Kosmoski J, and Glabe CG (1992). Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/βprotein. Proc Natl Acad Sci USA 89:7437-7441.
33. Koudinov AR, Koudinova N, Kumar A, Beavis RC, and Ghiso J (1996). Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Association with high density lipoproteins. Biochem Biophys Res Commun 223:592-597.
34. Kowal C, Herz J, Goldstein JL, Esser V, and Brown MS (1989). Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci USA 86:5810-5814.
35. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, and Roher AE (1996). Water-soluble A beta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077-4081.
36. Levy E, Carman MD, Fernandez Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, and Frangione B (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124-1126.
37. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulasisalo D, and Roses AD (1997). Apolipoprotein E-epsilon-2 and Alzheimer's disease-genotype influences pathologic phenotype. Neurology 48:515-519.
38. Luoma J, Hiltunen T, Sarkioja T, Moestrup SK, Gliemann J, Kodama T, Nikkari T, and Yla-Herttuala S (1994). Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 93:2014-2021.
39. Lupu F, Heim D, Bachmann F, and Kruithof EK (1994). Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries. Arterioscler Thromb 14:1438-1444.
40. Mazur Kolecka B, Frackowiak J, and Wisniewski HM (1995). Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's beta-amyloid peptide in cultured vascular smooth muscle cells. Brain Res 698:217-222.
41. Multhaupt HA, Gafvels ME, Kariko K, Jin H, Arenas-Elliot C, Goldman BI, Strauss JF III, Angelin B, Warhol MJ, and McCrae KR (1996). Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am J Pathol 148:1985-1997.
42. Namba Y, Tomonaga M, Kawasaki H, Otomo E, and Ikeda K (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541:163-166.
43. Naslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstrom AR, Bogdanovic N, Gandy SE, Lannfelt L, Terenius L, and Nordstedt C (1995). Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron 15:219-228.
44. Okuizumi K, Onodera O, Namba Y, Ikeda K, Yamamoto T, Seki K, Ueki A, Nanko S, Tanaka H, and Takahashi H (1995). Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet 11:207-209.
45. Okuizumi K, Onodera O, Seki K, Tanaka H, Namba Y, Ikeda K, Saunders AM, Pericak-Vance MA, Roses AD, and Tsuji S (1996). Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann Neurol 40:251-254.
46. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, and Thai LJ (1996). The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47:190-196.
47. Paresce DM, Ghosh RN, and Maxfield FR (1996). Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17:553-565.
48. Pirttila T, Mehta PD, Soininen H, Kim KS, Heinonen O, Paljarvi L, Kosunen O, Riekkinen P, Sr., and Wisniewski HM (1996). Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: Correlations with amyloid load in the brain. Arch Neurol 53:189-193.
49. Pitas RE (1990). Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells: Upregulation by phorbol esters. J Biol Chem 265:12722-12727.
50. Prelli F, Castano E, Glenner GG, and Frangione B (1988). Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 51:648-651.
51. Premkumar DR, Cohen DL, Hedera P, Friedland RP, and Kalaria RN (1996). Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 148:2083-2095.
52. Prior R, D'Urso D, Frank R, Prikulis I, Cleven S, Ihl R, and Pavlakovic G. (1996a). Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques. Am J Pathol 148:1749-1756.
53. Prior R, D'Urso D, Frank R, Prikulis I, and Pavlakovic G (1995). Experimental deposition of Alzheimer amyloid beta-protein in canine leptomeningeal vessels. Neuroreport 6:1747-1751.
54. Prior R, D'Urso D, Frank R, Prikulis I, Wihl G, and Pavlakovic G (1996b). Canine leptomeningeal organ culture: A new experimental model for cerebrovascular β-amyloidosis. J Neurosci Methods 68:143-148.
55. Pritchard ML, Saunders AM, Gaskell PC, Small GW, Conneally PM, Rosi B, Yamaoka LH, Roses AD, Haines JL, and Pericak-Vance MA (1996). No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci Lett 209:105-108.
56. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, and Ball MJ (1993). Beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90:10836-10840.
57. Roses AD (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47:387-400.
58. Ross R (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809.
59. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, and Ihara Y (1995). Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 38:421-428.
60. Strickland DK, Kounnas MZ, and Argraves WS (1995). LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 9:890-898.
61. Strittmatter WJ, Saunders AM, Schmechel D, Pericak VM, Enghild J, Salvesen GS, and Roses AD (1993). Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
62. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, and Ihara Y (1994). High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145:452-460.
63. Takahashi S, Oida K, Ookubo M, Suzuki J, Kohno M, Murase T, Yamamoto T, and Nakai T (1996). Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3. FEBS Lett 386:197-200.
64. Uchida K, Okuda R, Yamaguchi R, Tateyama S, Nakayama H, and Goto N (1993). Double-labeling immunohistochemical studies on canine senile plaques and cerebral amyloid angiopathy. J Vet Med Sci 55:637-642.
65. Vidal R, Garzuly F, Budka H, Lalowski M, Linke RP, Brittig F, Frangione B, and Wisniewski T (1996). Meningocerebrovascular amyloidosis associated with a novel transthyretin missense mutation at codon 18 (TTRD 18G). Am J Pathol 148:361-366.
66. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, and Schenk DB (1993). Characterization of β-amyloid peptide from human cerebrospinal fluid. J Neurochem 61:1965-1968.
67. Vinters HV, Wang ZZ, and Secor DL (1996). Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 8:179-195.
68. Wisniewski HM, Frackowiak J, and Mazur Kolecka B (1995). In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett 183:120-123.
69. Wisniewski HM and Wegiel J (1994). Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 87:233-241.
70. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, and Selkoe DJ (1992). Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease: An immunoelectron microscopic study. Am J Pathol 141:249-259.
71. Yang AJ, Knauer M, Burdick DA, and Glabe C (1995). Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J Biol Chem 270:14786-14792.